Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study

European Heart Journal

Volumn 18, Issue 3, 1997, Pages 443-449

  Grip, L ^a   Blomback, M ^a   Egberg, N ^a   Olsson, A ^a   Svane, B ^a   Velander, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antithrombin; Fibrin D dimer; Hypercoagulability; Percutaneous transluminal coronary angioplasty; Restenosis

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN III; D DIMER; FIBRIN; HEPARIN; PROTHROMBIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INFUSION; FEMALE; HUMAN; HYPERCOAGULABILITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0031038959     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015264     Document Type: Article

References (35)